These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28340974)

  • 1. Herpes Zoster Vaccine Coverage in Older Adults in the U.S., 2007-2013.
    Zhang D; Johnson K; Newransky C; Acosta CJ
    Am J Prev Med; 2017 Jan; 52(1):e17-e23. PubMed ID: 28340974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
    Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
    JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
    Lu PJ; Euler GL; Harpaz R
    Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease.
    Tseng HF; Luo Y; Shi J; Sy LS; Tartof SY; Sim JJ; Hechter RC; Jacobsen SJ
    Clin Infect Dis; 2016 Feb; 62(4):462-7. PubMed ID: 26671505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against zoster remains effective in older adults who later undergo chemotherapy.
    Tseng HF; Tartof S; Harpaz R; Luo Y; Sy LS; Hetcher RC; Jacobsen SJ
    Clin Infect Dis; 2014 Oct; 59(7):913-9. PubMed ID: 25097079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
    Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL
    Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual incidence rates of herpes zoster among an immunocompetent population in the United States.
    Johnson BH; Palmer L; Gatwood J; Lenhart G; Kawai K; Acosta CJ
    BMC Infect Dis; 2015 Nov; 15():502. PubMed ID: 26546419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years.
    Le P; Rothberg MB
    Ann Intern Med; 2015 Oct; 163(7):489-97. PubMed ID: 26344036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
    Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
    Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of social determinants in timely herpes zoster vaccination among older American adults.
    Shuvo S; Hagemann T; Hohmeier K; Chiu CY; Ramachandran S; Gatwood J
    Hum Vaccin Immunother; 2021 Jul; 17(7):2043-2049. PubMed ID: 33517829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
    Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
    Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study.
    Sun Y; Jackson K; Dalmon CA; Shapiro BL; Nie S; Wong C; Arnold BF; Porco TC; Acharya NR
    Vaccine; 2021 Jun; 39(29):3974-3982. PubMed ID: 34116874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
    Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
    Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
    Cunningham AL; Lal H; Kovac M; Chlibek R; Hwang SJ; Díez-Domingo J; Godeaux O; Levin MJ; McElhaney JE; Puig-Barberà J; Vanden Abeele C; Vesikari T; Watanabe D; Zahaf T; Ahonen A; Athan E; Barba-Gomez JF; Campora L; de Looze F; Downey HJ; Ghesquiere W; Gorfinkel I; Korhonen T; Leung E; McNeil SA; Oostvogels L; Rombo L; Smetana J; Weckx L; Yeo W; Heineman TC;
    N Engl J Med; 2016 Sep; 375(11):1019-32. PubMed ID: 27626517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
    Lal H; Cunningham AL; Godeaux O; Chlibek R; Diez-Domingo J; Hwang SJ; Levin MJ; McElhaney JE; Poder A; Puig-Barberà J; Vesikari T; Watanabe D; Weckx L; Zahaf T; Heineman TC;
    N Engl J Med; 2015 May; 372(22):2087-96. PubMed ID: 25916341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and disparity in zoster vaccine uptake in a managed care population.
    Hechter RC; Tartof SY; Jacobsen SJ; Smith N; Tseng HF
    Vaccine; 2013 Sep; 31(41):4564-8. PubMed ID: 23928461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.